UNSPSC 51161537: Enofelast

This classification denotes an anti-asthmatic agent with the molecular formula C16H15FO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3T93TS0430, chemically known as 2,6-dimethyl-4-(2-(4-fluorophenyl)ethenyl)phenol but generally known as enofelast, which bears US NIH Compound Identifier 6439222. European Medicines Agency schedules Enofelast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06538MIG.

UNSPSC 51161537 Enofelast is a Commodity code under which state and local governments procure generic multi-source pharmaceuticals and over-the-counter products for distribution across public health and human services facilities. The work involves supplying identified pharmaceutical products with specific National Drug Codes, SKUs, UPCs, and packaging configurations to authorized wholesalers serving participating state and local government agencies. Vendors must certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain contractual relationships with at least two of three designated wholesalers with chargeback systems, and demonstrate pricing flexibility through flat price, net price formats, or WAC-minus structures. Issuing bodies include cooperative purchasing alliances administering multi-state pharmaceutical contracts on behalf of member state agencies and local government facilities.

The Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities in Minnesota and Oregon. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and smaller percentages on compliance with administrative data format requirements, EDI capability, and agreement to a 3 percent administrative fee. Vendors must carry commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000. Contract term runs two years for new responders with optional extensions, or through June 30, 2028, for incumbent amendments. Products must be available in the marketplace by May 15, 2026, with awarded agreements effective July 1, 2026. Performance penalties range from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials.